Drug
pacritinib
Marketed as VONJO.
Generic name
pacritinib
Brand names
VONJO
First FDA approval
2022-02-28
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA208712 | VONJO | 2022-02-28 | SOBI |
Manufacturers
SOBI
Frequently asked questions
When was pacritinib FDA approved?
Earliest FDA approval on record: 2022-02-28.
What brand names are sold as pacritinib?
VONJO.
Sources
Appeal a pacritinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com